Background {#Sec1}
==========

Diaphragm dysfunction frequently develops in mechanically ventilated intensive care unit (ICU) patients and is associated with adverse clinical outcomes including prolonged mechanical ventilation and mortality \[[@CR1]--[@CR7]\]. It appears that non-physiological diaphragm activity plays an important role \[[@CR8]\], in which both disuse atrophy resulting from ventilator over-assist \[[@CR3], [@CR9], [@CR10]\] and high respiratory muscle effort resulting from ventilator under-assist \[[@CR11]--[@CR13]\] have been associated with diaphragm dysfunction in ICU patients. Therefore, there is a strong physiological rationale for monitoring diaphragm effort \[[@CR14]--[@CR16]\] and titrating support to maintain respiratory muscle activity within physiological limits \[[@CR17]\].

Variations in esophageal pressure (Pes) during breathing have been used for decades to quantify breathing effort. Recently, two state-of-the-art papers reviewed the technical and clinical aspects of esophageal pressure (Pes) monitoring in ICU patients \[[@CR18], [@CR19]\]. Limitations of this technique include strict control of balloon inflation volume and complexity of signal interpretation, in particular when expiratory muscles are recruited.

Diaphragm electromyography (EMG) is an alternative technique used to quantify breathing effort in ICU patients \[[@CR15]\]. Strong correlation has been reported between the electrical activity of the diaphragm (EAdi) and transdiaphragmatic pressure (Pdi) or Pes \[[@CR20], [@CR21]\]. The neuromechanical efficiency (NMEoccl), defined by delta airway pressure (∆Paw) divided by ∆EAdi measured during an end-expiratory occlusion, has been used to estimate the inspiratory effort breath by breath \[[@CR21], [@CR22]\]. This ratio describes how much pressure can be generated for each microvolt of EAdi signal, in other words how efficient the diaphragm is in generating pressure for a certain amount of electrical activity. This is of potential interest for monitoring diaphragm function (over time) and helps to titrate ventilatory support in order to minimize diaphragm dysfunction resulting from ventilator over-assist and under-assist \[[@CR17]\]. Today, this index has only been evaluated in studies including limited numbers of patients \[[@CR21]--[@CR24]\] and the repeatability, an essential characteristic for a diagnostic tool, has not been investigated at all. Therefore, the aim of our study was to evaluate the NMEoccl repeatability in mechanically ventilated ICU patients and its use to estimate the maximum inspiratory pressure generated by the inspiratory muscles (Pmus).

Methods {#Sec2}
=======

Study design and population {#Sec3}
---------------------------

This prospective cohort study was performed in an academic ICU. Adult patients, with a dedicated EAdi catheter (Maquet critical care, Solna Sweden) in situ and mechanically ventilated in neurally adjusted ventilator assist (NAVA) mode were eligible for inclusion. The institutional ethical committee approved the study protocol and informed consent was waived due to the non-invasive nature of the study and negligible risks.

Study protocol {#Sec4}
--------------

The EAdi catheter was positioned according to the manufacturer's instructions using a dedicated software tool on the Servo-i ventilator. The catheter position was verified before data acquisition. When patients exhibited a stable breathing pattern (i.e. no coughing, hiccups or disproportional differences in respiratory rate), measurements to assess respiratory muscle function were performed: (1) an end-expiratory occlusion maneuver (obtained by activating the expiratory hold button on the ventilator for one inspiratory effort) for measurement of NMEoccl and (2) a "zero assist breath" in which inspiratory support was decreased to zero for one single breath to calculate patient-ventilator breath contribution (PVBC) \[[@CR25], [@CR26]\]. Both maneuvers were repeated five times with at least a one-minute interval. The number of breaths between maneuvers was variable to prevent anticipation by the patient. Measurements were recorded and stored for offline analysis at time *T* = 0 and after 12 h (*T* = 12), 24 h (*T* = 24) and 72 h (*T* = 72).

Data acquisition {#Sec5}
----------------

EAdi, flow and Paw waveforms were acquired from the Servo-i ventilator via a RS232 serial port connected to a laptop with dedicated software (Servo Tracker version 4.1, Maquet, Solna, Sweden). Maximum inspiratory pressure (MIP) measurements were performed with a manovacumeter (Micro Respiratory Pressure Meter, Carefusion, Yorba Linda, CA, USA) connected to the endotracheal tube \[[@CR27]\].

Data analysis {#Sec6}
-------------

A software routine developed for MatLab (version R2016b, MathWorks Inc., Natick, MA, USA) was used for offline analysis.

NMEoccl was calculated in three different ways (Fig. [1](#Fig1){ref-type="fig"}): (1) by dividing ∆Paw by ∆EAdi \[[@CR21]\], in which ∆Paw is the difference in pressure between the lowest Paw during end-expiratory occlusion and the preceding end-expiratory pressure level, (2) by dividing the area under the curve (AUC) of Paw and EAdi, and (3) by dividing Paw and EAdi at fixed points (steps of 3 μV) on the EAdi waveform. The inspiratory time (Ti) was defined as the period between the onset of EAdi and 70% peak of EAdi. To investigate the effect of an occlusion on the inspiratory time, we compared Ti during occlusion with the Ti of three preceding unloaded breaths. To estimate Pmus under clinical conditions, the mean EAdi of five tidal breaths (before the end-expiratory occlusion) was multiplied by NMEoccl/1.5 \[[@CR21]\]. The correction of 1.5 compensates for the fact that in the presence of flow, the diaphragm generates less pressure for the same EAdi than during an occlusion \[[@CR21]\]. The tension-time index (TTI) was calculated as Pmus/MIP multiplied by the ratio of Ti to total respiratory cycle time (T~tot~) \[[@CR28]\].Fig. 1Example of a single neuromechanical efficiency index during an end-expiratory occlusion (NMEoccl) maneuver. The blue line represents the electrical activity of the diaphragm (EAdi) signal expressed in microvolts. The orange line represents the airway pressure (Paw) expressed in centimeters of water. As described above, the NMEoccl was calculated in three different ways, with the calculation based on (1) delta peak values of electrical activity of the diaphragm (EAdi) and Paw, shown as arrows; (2) area under the curve (AUC) of the EAdi and Paw signal, shown by diagonal lines and gray area, respectively; (3) using fixed points (steps of 3 μV) on the EAdi curve (during inspiration) and corresponding Paw, shown as black dots

Statistical analysis {#Sec7}
--------------------

Statistical analysis was performed with GraphPad PRISM (version 5.03 for Mac/Windows, Software Inc. San Diego, CA, USA). Data were analyzed as median ± interquartile range (IQR), except as stated otherwise. Statistical significance was indicated by a *p* value \<0.05.

The repeatability coefficient (RC) represents the absolute value by which two repeated measurements in one subject will differ in 95% of cases. The formula developed by Bland and Altman was used to calculated RC:

1.96 × √2 × Within-subject standard deviation (SD) \[[@CR29]\].

One-way analysis of variance (ANOVA) was used to obtain the within-subject SD with the subject as dependent factor and the repeated NMEoccl measurements as independent factors. Since the NMEoccl variability increased as the magnitude of NMEoccl increased, the ratio of a single NMEoccl measurement to the mean NMEoccl of five repeated measurements was used (see Additional file [1](#MOESM1){ref-type="media"}) \[[@CR29]\]. The correlation coefficient with repeated observation was used to investigate the within-subject correlation between Paw and EAdi \[[@CR30], [@CR31]\] (IBM SPSS Statistics version 22).

In addition, to obtain the within-subject NMEoccl variation, per patient for each time point a coefficient of variation (CoV) was calculated by the ratio of the within-subject SD to the mean. The median CoV was used to divide the study population into two groups with CoV higher or lower than median. The paired *t* test was used to test for differences in clinical parameters (that might affect NMEoccl variability) between both groups.

The Pearson correlation coefficient was calculated to test correlation between Ti and NMEoccl, and between TTI and Pmus. One-way ANOVA was used to investigate the changes in NMEoccl and inspiratory muscle pressure over time.

Results {#Sec8}
=======

Table [1](#Tab1){ref-type="table"} shows the main characteristics of the study population. A total 459 occlusions were performed (see Additional file [2](#MOESM2){ref-type="media"}). In 19 patients, the measurements could not be obtained at all four time points due to various reasons: extubation (*n* = 7), agitation (*n* = 2), low EAdi (*n* = 3), return to controlled mode (n = 2), death (*n* = 1) and others (*n* = 4).Table 1Main characteristics of the study populationCharacteristics*N* = 31Age (years), median \[IQR\]69 \[55.5--72\]Sex, male/female22/9BMI (kg/m^2^), median \[IQR\]24.7 \[21.6--26\]Comorbidity, *n* (%) Cardiac diseases9 (29%) Diabetes mellitus6 (19%) COPD4 (13%)Reason for admission, *n* (%) Pneumonia13 (42%) Postoperative8 (26%) Trauma7 (23%) Others3 (10%)ARDS at admission, *n* (%)9 (29%)Sepsis during admission, *n* (%)6 (19%)Duration of MV on *T* = 0 (days), median \[IQR\]10 \[8.5--18.5\] Partially supported mode before *T* = 09 \[4--14\] Controlled mode before *T* = 01 \[0--3.5\]Total days of MV (days), median \[IQR\]24 \[14.5--29.5\]NAVA level, median \[IQR\]0.7 \[0.5--1.2\]Tidal volume (ml), median \[IQR\]450 \[381--554\]Respiratory rate (per minute), median \[IQR\]25 \[18--30\]PEEP (cmH~2~O), median \[IQR\]8 \[6--10\]Use of opioids/sedatives, *n* (%)16 (51.6%)Total LOS ICU (days), median \[IQR\]26 \[20--34\]Total LOS hospital (days), median \[IQR\]41 \[23--52.5\]Died within the study period, *n* (%)1 (3%)*Abbreviations: ARDS* acute respiratory distress syndrome, *BMI* body mass index, *COPD* chronic obstructive pulmonary disease, *ICU* intensive care unit, *IQR* interquartile range, *LOS* length of stay, *MV* mechanical ventilation, *NAVA* neurally adjusted ventilatory assist, *PEEP* positive end-expiratory pressure

NMEoccl variability {#Sec9}
-------------------

A representative NMEoccl maneuver is shown in Fig. [1](#Fig1){ref-type="fig"}. At *T* = 0, 149 maneuvers were obtained in 31 patients, 6 maneuvers were lost due to technical issues. Mean ∆Paw was 14.1 ± 7.9 cmH~2~O and mean ∆EAdi 14.8 ± 9.9 μV. Mean NMEoccl was 1.22 ± 0.86 cmH~2~O/μV (ranging from 0.41 to 3.56 cmH~2~O/μV), with a RC of 82.6%. This implies that when NMEoccl is 1.0 cmH~2~O/μV, it is expected with a probability of 95% that the subsequent measured NMEoccl will be between 0.17 and 1.83 cmH~2~O/μV. When the EAdi of this patient during normal breathing is 10 μV, the estimated pressure generated by the inspiratory muscles would be somewhere between 1.1 cmH~2~O and 12.2 cmH~2~O (calculated as EAdi \* NMEoccl/1.5, see "[Methods](#Sec2){ref-type="sec"}"). In addition, the RC of NMEoccl calculated by the AUC and at fixed points on the EAdi curve (Fig. [2](#Fig2){ref-type="fig"}) remained high: 87.7% for AUC and 85.5--175.9% at fixed points. The RC of the separate components of NMEoccl was 95.7% for EAdi and 73.9% for Paw. Figure [2](#Fig2){ref-type="fig"} shows there was moderate correlation between ∆EAdi and ∆Paw in the individual patient (mean *r* = 0.52, *p* \< 0.0005; ranging from *r* = − 0.90 to *r* = 1.0).Fig. 2Overview of the correlation of airway pressure (Paw) peak and electrical activity of the diaphragm (EAdi) peak of all maneuvers at time *T* = 0. Each color represents an individual patient with five repeated measurements (dots) and the corresponding slope (line)

Upon visual inspection it appeared that some of the EAdi tracings exhibit a rather non-physiological shape: a plateau during inspiration (while an increase would be expected) or at maximum inspiration, or a delayed increase in EAdi relative to the decrease in Paw (Fig. [3](#Fig3){ref-type="fig"}). It was reasoned that non-physiological-appearing EAdi waveforms contribute to the high NMEoccl variability. Additional file [2](#MOESM2){ref-type="media"} shows every occlusion maneuver obtained in this study. Different mathematical approaches were used in order to try to objectively detect and exclude non-physiological EAdi waveforms (See Additional file [3](#MOESM3){ref-type="media"}). Despite these mathematical approaches the NMEoccl repeatability remained high with a RC of 63.4%.Fig. 3Four examples of electrical activity of the diaphragm (EAdi) waveform irregularities during an end-expiratory occlusion. The blue line represents the EAdi signal expressed in microvolts. The orange line represent the airway pressure (Paw) expressed in centimeters of water. **a** Slope \< 0 during the ascending part of the EAdi waveform. **b** Delay in start of EAdi peak. **c** EAdi peak cut off. **d** Split EAdi peak

Finally, we pragmatically selected three out of five occlusions with the lowest variability and averaged the three values to obtain a single NMEoccl for each individual patient. This approach reduces the influence of erroneous values, irrespective of the origin, and will result in a more reproducible NMEoccl value. As a result, the RC improved to 29.8%. This approach was used for subsequent analysis.

Correlation of NMEoccl variability with clinical parameters and inspiratory time {#Sec10}
--------------------------------------------------------------------------------

The median CoV NMEoccl at *T* = 0 was 23.1% (IQR 18.7--29.9%). After dividing the study population into two groups with CoV higher or lower than median, respectively, no significant differences in clinical parameters were found (see Additional file [4](#MOESM4){ref-type="media"}). Median Ti during occlusion was 0.51 s (IQR 0.35--0.65 s) and of the preceding breaths 0.65 s (IQR 0.48--0.84 s). On average, in 48% of the measurements within a patient, Ti of the occluded breath was longer compared to Ti of the preceding breaths. Only moderate negative correlation was found between Ti and NMEoccl (*r* = − 0.219).

Changes in NMEoccl over time {#Sec11}
----------------------------

Twelve patients completed the 72 h study period. In these patients, NMEoccl at *T* = 0 was 0.8 cmH~2~O/μV (IQR 0.7--1.1 cmH~2~O/μV) and did not change over time (*p* = 0.75); 0.7 cmH~2~O/μV (IQR 0.4--0.9 cmH~2~O/μV), 0.8 cmH~2~O/μV (IQR 0.6--1.1 cmH~2~O/μV), 0.9 cmH~2~O/μV (IQR 0.6--1.3 cmH~2~O/μV) for *T* = 12, *T* = 24 and *T* = 72, respectively.

Diaphragm muscle effort {#Sec12}
-----------------------

The mean EAdi of five unloaded breaths before the end-expiratory occlusion were used to calculate Pmus. At *T* = 0, median Pmus was 9.4 cmH~2~O (IQR 6.0--12.8 cmH~2~O) and did not change over time (*p* = 0.58); 10.4 cmH~2~O (IQR 5.4--15.4 cmH~2~O), 10.7 cmH~2~O (IQR 4.8--13.1 cmH~2~O) and 8.2 cmH~2~O (IQR 6.0--15.9 cmH~2~O) for *T* = 12, T = 24 and *T* = 72, respectively. The median Pmus varied widely among patients, ranging from 1.8 to 36.0 cmH~2~O. Based on previous literature \[[@CR21], [@CR23]\], we defined a physiological Pmus between 5 and 10 cmH~2~O. At *T* = 0, 6 patients (19.4%) had a mean Pmus \< 5cmH~2~O and 12 patients (38.7%) \> 10cmH~2~O, indicating ventilator over-assist or under-assist, respectively.

MIP was obtained in 15 patients in the week before or after the NME measurements, which allowed us to calculate TTI. Median MIP was 29 cmH~2~O (IQR 24--38 cmH~2~O) and median TTI was 0.12 (IQR 0.08--0.17). Figure [4](#Fig4){ref-type="fig"} shows the relationship between TTI and Pmus.Fig. 4Overview of correlation between the tension-time index and inspiratory pressure (Pmus) in 15 patients in whom maximum inspiratory pressure was measured (dots). The dotted line represents the cut off for diaphragm fatigue \[[@CR36]\]

Discussion {#Sec13}
==========

The main findings of the present study can be summarized as follows: (1) repeated measurements of NMEoccl within an individual patient exhibited unacceptably high variation, indicating that a single NMEoccl cannot be used to estimate pressure generated by the inspiratory muscles; (2) no correlation was found between NMEoccl variability and clinical parameters; (3) extensive waveform analyses did not improve the repeatability of NMEoccl; (4) NMEoccl and Pmus remain stable over time in a heterogeneous group of patients and (5) both low and high diaphragm effort are common in this cohort of patients on partially supported mode.

NMEoccl variability {#Sec14}
-------------------

Variability of both components of NMEoccl (Paw and EAdi) is expected given the variability in inspiratory drive, even during occlusions. However, NMEoccl itself is independent from respiratory drive and should therefore be more stable from breath to breath.

Beck and colleagues reported a linear relationship between EAdi and Pdi in healthy subjects, at least up to 75% of maximum force \[[@CR32]\]. Their subsequent study also demonstrated a linear relationship between EAdi and Pdi in patients with acute respiratory failure \[[@CR20]\]. Bellani et al. showed that NMEoccl derived from airway pressure closely reflects NME during normal breathing (NMEdyn) derived from Pes and concluded that calculation of NMEoccl allows a clinically valuable estimate of inspiratory effort \[[@CR21]\]. In this latter study, two end-expiratory occlusions were obtained in each patient, but repeatability was not reported. Furthermore, they report that despite changes in level of support, NMEoccl remained rather stable within individual patients, as supported by the linear relationship between Pmus and EAdi (*r*^2^ = 0.78) \[[@CR21]\]. This is in apparent contrast with our findings, as we found only moderate correlation between Pmus and EAdi (Fig. [2](#Fig2){ref-type="fig"}). However, differences in data analysis should be acknowledged. Bellani used the Pearson correlation coefficient to test the correlation between Paw and EAdi, in which all measurements from different patients were analyzed together as if they were from a single patient. However, the variability of *between-subject* measurements is different compared to the variability of the *within-subject* measurements \[[@CR33]\]. Therefore, calculating the correlation coefficient of repeated observations, as in the current study, seems more appropriate \[[@CR30], [@CR31]\]. Indeed, Fig. [2](#Fig2){ref-type="fig"} demonstrates that the slope of Paw and EAdi in the individual patient is highly variable. This is consistent with the results of Bellani, exhibiting high inter-individual variability \[[@CR21]\].

The high NMEoccl repeatability reported in the current study precludes its application in clinical practice. Based on visual inspection of the EAdi waveforms, we proposed that suboptimal filtering and replacement of cardiac electric activity by the ventilator software are important. Several techniques for waveform analyses were applied, but did not improve repeatability, suggesting that in addition to suboptimal filtering other factors might be involved. Beck et al. showed that an increase in volume from functional reserve capacity (FRC) to total lung capacity (TLC) reduces Pdi by 60% for a given EAdi \[[@CR34]\]. Similarly, muscle weakness may affect NMEoccl, but both are unlikely to explain the high variability in our study, given that all measurements were obtained in a time window of 5--10 min.

As none of the techniques for waveform analyses resulted in improved NMEoccl repeatability, a more pragmatic approach was explored that is also feasible in clinical practice. In thermodilution cardiac output measurements, three repeated measurements are averaged, provided that these values are within 10% of their average. If not, a total of five measurements are performed in which the lowest and highest value are eliminated \[[@CR35]\]. In our study, this strategy reduced the influence of erroneous NMEoccl values, irrespective of the cause, and will result in a more reproducible value of NMEoccl.

NMEoccl as monitoring tool {#Sec15}
--------------------------

Theoretically, the NMEoccl could be helpful to titrate ventilator support in patients on partially supported modes. NMEoccl is calculated by dividing ∆Paw by ∆EAdi during an end-expiratory occlusion. During an occlusion ∆Paw equals ∆Pmus and therefore NMEoccl can be obtained without direct measurement of Pmus (requiring an esophageal balloon). Rearranging this formula to Pmus = NMEoccl \* EAdi allows calculation of Pmus breath by breath, after dividing this value by 1.5 to correct for differences in NME obtained under static and dynamic conditions \[[@CR21]\]. Interestingly, NMEoccl may be used to evaluate respiratory muscle function over time. A decrease in NMEoccl indicates that the respiratory muscles are less efficient in converting electrical activity into pressure. Possible causes for variability in NMEoccl require further studies, but may include intrinsic positive end-expiratory pressure (PEEP) and impaired function of the contractile proteins.

In our study population there were no significant changes in NMEoccl over time (*p* = 0.75), which corresponds to the results of Bellani et al. \[[@CR23]\]. However, it should be noted that during our study period the ventilatory settings were not fixed, which might explain why NMEoccl did not change over time.

In our study Pmus varied among patients but remained relatively stable in individual patients over time. In some patients estimated inspiratory effort was \> 20 cmH~2~O. An important question is whether a relatively high inspiratory pressure generated by the respiratory muscles may result in the development of contractile fatigue. A TTI ≥ 0.15 puts the diaphragm at risk of development of fatigue \[[@CR36]\]. In our study, all patients except for two, with a Pmus \< 12 cmH~2~O, had a TTI \< 0.15. This might suggest that titration of ventilatory support to a pressure \< 12 cmH~2~O could limit the risk of fatigue development. However, this has to be studied before it can be applied in clinical practice.

Strengths and limitations {#Sec16}
-------------------------

The strengths of our study are the high number of occlusions analyzed and the fact that at each time point five repeated occlusions were obtained. This allows thorough analysis of the repeatability of NMEoccl and provides methods to improve its variability under clinical conditions. In addition, several waveform analysis techniques were performed to evaluate the high NMEoccl variability; however, this did not improve the RC for NMEoccl. It was suggested that suboptimal filtering might be important. Software engineers should further improve ventilator software for EAdi signal filtering.

Several limitations should be acknowledged. First, patients in our study did not have an esophageal balloon in situ and therefore we could not validate our measurements against the gold standard. However, previous studies have shown excellent correlation between ∆Paw and ∆Pes during an occlusion maneuver \[[@CR37]--[@CR39]\]. Second, our study was conducted in a single center and in a selected group of ICU patients. The generalizability of the findings needs to be assessed.

Conclusion {#Sec17}
==========

End-expiratory occlusion allows measurement of static change in EAdi and Paw for calculation of NMEoccl. This maneuver is simple to conduct and safe in ICU patients ventilated in partially supported mode. However, the present study demonstrates that a single maneuver cannot be used to calculate NMEoccl, given the unacceptably high variability. Further studies should be conducted to improve software for EAdi analysis for this specific purpose. For now, selecting three out of five occlusions with the lowest variability seems to be the best method to estimate inspiratory muscle effort from EAdi.

Additional files
================

 {#Sec18}

Additional file 1:NMEoccl calculated as a ratio. Since the variability of NMEoccl increased as the magnitude of the NMEoccl increased, the ratio of a single NMEoccl value to the mean NMEoccl of five repeated measurements was used to calculate the variability of NMEoccl \[[@CR26]\]. (A) The difference in NMEoccl is expressed against mean NMEoccl. (B) the ratio of NMEoccl is expressed against mean NMEoccl. (TIF 70 kb) Additional file 2:Overview of the five repeated occlusions in each individual patient. The blue line represents the EAdi signal expressed in microvolts. The orange line represents the airway pressure (Paw) expressed in cmH~2~O. (DOCX 1942 kb) Additional file 3:Extensive waveform analyses. This file gives an overview of the extensive waveform analyses that are performed, in order to objectively detect and exclude non-physiological EAdi waveforms. (DOCX 36 kb) Additional file 4:Correlation of clinical parameters and NMEoccl variability at *T* = 0. First, the coefficient of variation (CoV) was calculated for each patient. The median CoV for NMEoccl at *T* = 0 was 23.1% (IQR 18.7--29.9%). The study population was divided in two groups, with the CoV higher or lower than the median, respectively. CoV = coefficient of variation; COPD = chronic obstructive pulmonary disease; EAdi = electrical activity of the diaphragm; HR = heart rate; IQR = interquartile range; NAVA = neutrally adjusted ventilatory assist; RASS = Richmond agitation sedation scale; RR = respiratory rate; VT = tidal volume. (DOCX 18 kb)
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